Intranasal carbetocin formulations and methods for the treatment of autism
Methods and compositions containing oxytocin or an oxytocin analog, such as carbetocin, are provided for the prevention and treatment of autism spectrum disorders, related disorders and symptoms of such disorders. The methods and compositions of this disclosure are effective in the treatment of soci...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GESTY JASON PHILIP SILENO ANTHONY P PEDDAKOTA LALIT RAJ SESTAK JOSHUA ORION SHARGHI KAYVON EMILE BELLAMY GARLAND M QUAY STEVEN C LEONARD ALEXIS KAYS COSTANTINO HENRY R |
| description | Methods and compositions containing oxytocin or an oxytocin analog, such as carbetocin, are provided for the prevention and treatment of autism spectrum disorders, related disorders and symptoms of such disorders. The methods and compositions of this disclosure are effective in the treatment of social withdrawal, eye contact avoidance, repetitive behaviors, anxiety, attention deficit, hyperactivity, depression, loss of speech, verbal communication difficulties, aversion to touch, visual difficulties, comprehension difficulties, and sound and light sensitivity. Additional compositions and methods are provided which employ oxytocin or an oxytocin analog in combination with a secondary or adjunctive therapeutic agent to yield more effective treatment tools against autism spectrum disorders and related disorders. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US9023793B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US9023793B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US9023793B23</originalsourceid><addsrcrecordid>eNqNyrEKwjAQgOEsDlJ9h3sBoTSDdFUq6qrO5UwvNJDcldz1_UXwAZz-4fu37n5jq8iomCFgfZNJSAxRalkzWhJWQJ6gkM0y6RfAZgKrhFaIDSQCrpa07NwmYlba_9o4uAzP8_VAi4ykCwZisvH16NvOH3t_6vwfywcCmjVa</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Intranasal carbetocin formulations and methods for the treatment of autism</title><source>esp@cenet</source><creator>GESTY JASON PHILIP ; SILENO ANTHONY P ; PEDDAKOTA LALIT RAJ ; SESTAK JOSHUA ORION ; SHARGHI KAYVON EMILE ; BELLAMY GARLAND M ; QUAY STEVEN C ; LEONARD ALEXIS KAYS ; COSTANTINO HENRY R</creator><creatorcontrib>GESTY JASON PHILIP ; SILENO ANTHONY P ; PEDDAKOTA LALIT RAJ ; SESTAK JOSHUA ORION ; SHARGHI KAYVON EMILE ; BELLAMY GARLAND M ; QUAY STEVEN C ; LEONARD ALEXIS KAYS ; COSTANTINO HENRY R</creatorcontrib><description>Methods and compositions containing oxytocin or an oxytocin analog, such as carbetocin, are provided for the prevention and treatment of autism spectrum disorders, related disorders and symptoms of such disorders. The methods and compositions of this disclosure are effective in the treatment of social withdrawal, eye contact avoidance, repetitive behaviors, anxiety, attention deficit, hyperactivity, depression, loss of speech, verbal communication difficulties, aversion to touch, visual difficulties, comprehension difficulties, and sound and light sensitivity. Additional compositions and methods are provided which employ oxytocin or an oxytocin analog in combination with a secondary or adjunctive therapeutic agent to yield more effective treatment tools against autism spectrum disorders and related disorders.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150505&DB=EPODOC&CC=US&NR=9023793B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150505&DB=EPODOC&CC=US&NR=9023793B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GESTY JASON PHILIP</creatorcontrib><creatorcontrib>SILENO ANTHONY P</creatorcontrib><creatorcontrib>PEDDAKOTA LALIT RAJ</creatorcontrib><creatorcontrib>SESTAK JOSHUA ORION</creatorcontrib><creatorcontrib>SHARGHI KAYVON EMILE</creatorcontrib><creatorcontrib>BELLAMY GARLAND M</creatorcontrib><creatorcontrib>QUAY STEVEN C</creatorcontrib><creatorcontrib>LEONARD ALEXIS KAYS</creatorcontrib><creatorcontrib>COSTANTINO HENRY R</creatorcontrib><title>Intranasal carbetocin formulations and methods for the treatment of autism</title><description>Methods and compositions containing oxytocin or an oxytocin analog, such as carbetocin, are provided for the prevention and treatment of autism spectrum disorders, related disorders and symptoms of such disorders. The methods and compositions of this disclosure are effective in the treatment of social withdrawal, eye contact avoidance, repetitive behaviors, anxiety, attention deficit, hyperactivity, depression, loss of speech, verbal communication difficulties, aversion to touch, visual difficulties, comprehension difficulties, and sound and light sensitivity. Additional compositions and methods are provided which employ oxytocin or an oxytocin analog in combination with a secondary or adjunctive therapeutic agent to yield more effective treatment tools against autism spectrum disorders and related disorders.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQgOEsDlJ9h3sBoTSDdFUq6qrO5UwvNJDcldz1_UXwAZz-4fu37n5jq8iomCFgfZNJSAxRalkzWhJWQJ6gkM0y6RfAZgKrhFaIDSQCrpa07NwmYlba_9o4uAzP8_VAi4ykCwZisvH16NvOH3t_6vwfywcCmjVa</recordid><startdate>20150505</startdate><enddate>20150505</enddate><creator>GESTY JASON PHILIP</creator><creator>SILENO ANTHONY P</creator><creator>PEDDAKOTA LALIT RAJ</creator><creator>SESTAK JOSHUA ORION</creator><creator>SHARGHI KAYVON EMILE</creator><creator>BELLAMY GARLAND M</creator><creator>QUAY STEVEN C</creator><creator>LEONARD ALEXIS KAYS</creator><creator>COSTANTINO HENRY R</creator><scope>EVB</scope></search><sort><creationdate>20150505</creationdate><title>Intranasal carbetocin formulations and methods for the treatment of autism</title><author>GESTY JASON PHILIP ; SILENO ANTHONY P ; PEDDAKOTA LALIT RAJ ; SESTAK JOSHUA ORION ; SHARGHI KAYVON EMILE ; BELLAMY GARLAND M ; QUAY STEVEN C ; LEONARD ALEXIS KAYS ; COSTANTINO HENRY R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US9023793B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2015</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GESTY JASON PHILIP</creatorcontrib><creatorcontrib>SILENO ANTHONY P</creatorcontrib><creatorcontrib>PEDDAKOTA LALIT RAJ</creatorcontrib><creatorcontrib>SESTAK JOSHUA ORION</creatorcontrib><creatorcontrib>SHARGHI KAYVON EMILE</creatorcontrib><creatorcontrib>BELLAMY GARLAND M</creatorcontrib><creatorcontrib>QUAY STEVEN C</creatorcontrib><creatorcontrib>LEONARD ALEXIS KAYS</creatorcontrib><creatorcontrib>COSTANTINO HENRY R</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GESTY JASON PHILIP</au><au>SILENO ANTHONY P</au><au>PEDDAKOTA LALIT RAJ</au><au>SESTAK JOSHUA ORION</au><au>SHARGHI KAYVON EMILE</au><au>BELLAMY GARLAND M</au><au>QUAY STEVEN C</au><au>LEONARD ALEXIS KAYS</au><au>COSTANTINO HENRY R</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Intranasal carbetocin formulations and methods for the treatment of autism</title><date>2015-05-05</date><risdate>2015</risdate><abstract>Methods and compositions containing oxytocin or an oxytocin analog, such as carbetocin, are provided for the prevention and treatment of autism spectrum disorders, related disorders and symptoms of such disorders. The methods and compositions of this disclosure are effective in the treatment of social withdrawal, eye contact avoidance, repetitive behaviors, anxiety, attention deficit, hyperactivity, depression, loss of speech, verbal communication difficulties, aversion to touch, visual difficulties, comprehension difficulties, and sound and light sensitivity. Additional compositions and methods are provided which employ oxytocin or an oxytocin analog in combination with a secondary or adjunctive therapeutic agent to yield more effective treatment tools against autism spectrum disorders and related disorders.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US9023793B2 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Intranasal carbetocin formulations and methods for the treatment of autism |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T18%3A08%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GESTY%20JASON%20PHILIP&rft.date=2015-05-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS9023793B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |